MRK vs GILD
By Alex · Tickerpine
Merck & Co., Inc. vs Gilead Sciences, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | GILD |
|---|---|---|
| Price | $147.76 | $168.08 |
| Market cap | $364.26B | $208.48B |
| P/E ratio | 149.3 | — |
| ROE | 5.06% | -22.45% |
| Profit margin | 3.64% | -12.46% |
| Revenue growth | 4.70% | 6.80% |
| Dividend yield | 2.30% | 1.95% |
| Beta | 0.12 | 0.37 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs GILD in plain English
- MRK is the bigger company — about 1.7× the market cap of GILD.
- MRK earns a higher return on equity (5% vs -22%).
- GILD is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.30% vs 1.95%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
GILD return calculator
See what $1,000 in Gilead Sciences, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.